Molecular Hub of Autism?

Researchers identify a network that includes many genes previously linked to autism spectrum disorders.

By | December 30, 2014

FLICKR, BOREIO SELASAutism spectrum disorders (ASD) are notoriously complex: they’re associated with hundreds of genes. Now, researchers led by Stanford University’s Michael Snyder have identified a molecular network that comprises many of these genes, and may underlie the development of ASD. The findings, published today (December 30) in Molecular Systems Biology, point to potentially important protein interactions as well as novel genes that may be linked to the disorders.

“The study of autism disorders is extremely challenging due to the large number of clinical mutations that occur in hundreds of different human genes associated with autism,” Snyder said in a press release. “We therefore wanted to see to what extent shared molecular pathways are perturbed by the diverse set of mutations linked to autism.”

Turning to BioGrid, a database of protein and genetic interactions, the researchers identified a module of 119 interacting proteins that include “a very strong enrichment for autism genes,” Snyder explained. Sequencing the genomes of six ASD patients demonstrated that this module was associated with the development of the disorders, and sequencing of 19 patients’ exomes further confirmed a role for the candidate autism genes present within the module. Finally, an analysis of gene-expression data from the Allen Human Brain Atlas revealed roles for the corpus callosum and oligodendrocyte cells in ASD.

“This protein interaction module contained genes involved in the development and function of oligodendrocytes in the corpus callosum, which directly supports the idea that autism might be due to poor connectivity between brain hemispheres,” study coauthor Jingjing Li, a postdoc in Snyder’s lab, said in a press release. “These findings tell us that we may have to focus our attention on genes involved in different cell types and brain regions, rather than those that had initially raised the suspicions of autism researchers.”

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham